Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent
1 other identifier
interventional
40
1 country
1
Brief Summary
Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
December 10, 2025
CompletedStudy Start
First participant enrolled
December 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedDecember 10, 2025
November 1, 2025
3 months
November 18, 2025
December 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
ureteral reflux
Injection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.
Intraoperative
Assessment the Ureteral Stent Symptom Questionnaire (USSQ)
Ureteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents. USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains: Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.
Postoperative: 1st and 7th day, before stent removal
Secondary Outcomes (5)
Patient's height
Preoperative
Patient's weight
Preoperative
Body mass index (BMI)
Preoperative
Operative time
Intraoperative (measured from start to end of procedure)
Surgery
Preoperative
Study Arms (2)
Group I (DJ stent)
ACTIVE COMPARATORNon-prestented patients who will insert a standard DJ stent after surgery
Group II (modified DJ stent)
EXPERIMENTALNon-prestented patients who will insert a modified DJ stent after surgery
Interventions
Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting
Eligibility Criteria
You may qualify if:
- Patients aged 18 years and older
- Patients with kidney stones
- Patients with ureteral stones
You may not qualify if:
- Congenital anomalies of the urinary tract
- Urinary tract infections
- Upper urinary tract obstruction
- Complicated ureteroscopy (e.g., ureteral perforation)
- Pregnancy
- Pre-stented patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Luke's Clinical Hospital
Saint Petersburg, Outside U.S./Canada, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Urologist
Study Record Dates
First Submitted
November 18, 2025
First Posted
December 10, 2025
Study Start
December 28, 2025
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
December 10, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
We are currently finalizing our data sharing policy. All required individual participant data underlying the reported results will be made available for regulatory purposes immediately upon request, and may be shared with researchers following publication after de-identification, contingent on submission of a methodologically sound proposal and compliance with institutional and national privacy regulations